Key Capital Corporation Stock

Stocks

Market Closed - OTC Markets Other stock markets 15:20:40 2026-04-13 EDT			5-day change	1st Jan Change
0.000100 ^USD	+9,900.00%		-.--%	-

20-03-05	Key Capital Corporation Seeks Partners for Development of KV-C19 Coronavirus Therapeutic Vaccine Using Proven Immunotherapy Platform	CI
19-11-13	Key Capital Corporation completed the acquisition of 20% stake in GoldVault.	CI

Timeframe

Style

20-03-05	Key Capital Corporation Seeks Partners for Development of KV-C19 Coronavirus Therapeutic Vaccine Using Proven Immunotherapy Platform	CI
19-11-13	Key Capital Corporation completed the acquisition of 20% stake in GoldVault.	CI
19-05-16	Key Capital Partners Cancer Research Center to Trial Breakthrough Immunotherapy Vaccine	CI
19-05-16	Key Capital Corporation Announces Immunitor Hepcortespenlisimut-L Oral Vaccine Demonstrated Highly Promising Results in Late-Stage Liver Cancer Patients	CI
19-04-01	Key Capital Corporation agreed to acquire 20% stake in GoldVault for $2.4 million.	CI
18-11-08	SMTC Corporation acquired MC Test Service, Inc. from a group of shareholders for $70 million.	CI
17-11-30	Key Capital Corporation Enters Licensing and Development Agreement with Crypto Investor, Inc	CI
17-11-27	Key Capital Corporation Establishes Blockchain Fintech Division; Signs Gold Pre-Purchase Agreement with GoldCrypto.io to Deliver Gold Bullion	CI
17-04-13	Key Capital Corporation Announces Terminal Liver Cancer Trial Results Publication	CI
17-03-07	Key Capital Corporation Enters in to Licensing Agreement with Immunitor, Inc	CI
15-08-16	GeoGlobal Resources Inc. announced that it has received $1.2 million in funding from Key Capital Corporation	CI
14-09-12	Key Capital Corporation acquired 65% stake in GeoGlobal Resources Inc..	CI
14-08-29	Key Capital Corporation Reports Earnings Results for the First Quarter Ended June 30, 2014	CI

25-04-23	Iron Key Capital Unveils 2025 Whitepaper: "Why Seed, Why Now?" Making the Case for Early-Stage Venture Investing in Web3 and AI	AQ
20-03-10	Key Capital Coronavirus Treatment Advantage	GL
20-03-05	Key Capital : Seeks Partners for Development of KV-C19 Coronavirus Therapeutic Vaccine Using Proven Immunotherapy Platform	AQ
19-11-20	Key Capital Progresses Hospital Cancer Research and Treatment Center	GL
19-11-14	Key Capital Acquires 20% of GoldVault	GL